SynerFuse Spinal Fusion and Neuromodulation Proof of Concept Study

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of the study is to evaluate the safety and tolerability of DRG stimulation when placing a neurostimulator during the same procedure as implantation of spinal fixation with or without interbody cage systems in patients with chronic back and/or leg pain requiring single level spinal fusion.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 21
Maximum Age: 80
Healthy Volunteers: f
View:

• Indicated for a single level or two level adjacent spinal fusion having back pain and radiculopathy

• Have been diagnosed with chronic, intractable pain of the lower back and/or leg refractory to conservative therapy for at least 3 of months

• At least 6 months since last surgical procedure on the spine

• Be 21 years of age or older at the time of enrollment

• Be willing and capable of giving informed consent

• Be willing and able to comply with study-related requirements

Locations
United States
Indiana
South Bend Orthopaedics
RECRUITING
Mishawaka
Minnesota
University of Minnesota
RECRUITING
Minneapolis
Contact Information
Primary
Gabi Molnar
Gabi@SynerFuse.com
612-217-2914
Time Frame
Start Date: 2022-01-06
Estimated Completion Date: 2024-10
Participants
Target number of participants: 20
Treatments
Experimental: DRG Neurostimulation with Spinal Fusion
Related Therapeutic Areas
Sponsors
Leads: SynerFuse, Inc

This content was sourced from clinicaltrials.gov

Similar Clinical Trials